Treace Medical Concepts (TMCI) Competitors $5.59 -0.02 (-0.36%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$5.57 -0.02 (-0.36%) As of 08/5/2025 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. SSII, CDRE, NVCR, AORT, ESTA, BLFS, TNDM, PLSE, MDXG, and INMDShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include SS Innovations International (SSII), Cadre (CDRE), NovoCure (NVCR), Artivion (AORT), Establishment Labs (ESTA), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), MiMedx Group (MDXG), and InMode (INMD). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors SS Innovations International Cadre NovoCure Artivion Establishment Labs BioLife Solutions Tandem Diabetes Care Pulse Biosciences MiMedx Group InMode Treace Medical Concepts (NASDAQ:TMCI) and SS Innovations International (NASDAQ:SSII) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings. Do analysts prefer TMCI or SSII? Treace Medical Concepts presently has a consensus price target of $10.52, indicating a potential upside of 88.13%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than SS Innovations International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33SS Innovations International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to TMCI or SSII? In the previous week, Treace Medical Concepts had 5 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for Treace Medical Concepts and 1 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.16 beat Treace Medical Concepts' score of 0.63 indicating that SS Innovations International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, TMCI or SSII? SS Innovations International has lower revenue, but higher earnings than Treace Medical Concepts. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.68-$55.74M-$0.85-6.58SS Innovations International$20.65M62.35-$19.15MN/AN/A Is TMCI or SSII more profitable? Treace Medical Concepts has a net margin of -25.14% compared to SS Innovations International's net margin of -67.73%. Treace Medical Concepts' return on equity of -48.69% beat SS Innovations International's return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-25.14% -48.69% -24.59% SS Innovations International -67.73%-70.64%-32.95% Do insiders & institutionals believe in TMCI or SSII? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryTreace Medical Concepts beats SS Innovations International on 10 of the 13 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$352.81M$7.01B$5.59B$9.53BDividend YieldN/A1.31%4.73%4.14%P/E Ratio-6.5820.9628.9123.88Price / Sales1.6858.49445.5998.82Price / CashN/A21.0735.6858.35Price / Book3.095.608.165.60Net Income-$55.74M$178.18M$3.25B$265.26M7 Day Performance0.90%-1.52%1.17%-0.14%1 Month Performance-7.62%-3.19%8.27%6.08%1 Year Performance-16.07%12.09%29.19%24.22% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.3563 of 5 stars$5.59-0.4%$10.52+88.1%-11.7%$352.81M$209.36M-6.58250News CoverageUpcoming EarningsSSIISS Innovations InternationalN/A$7.20+0.3%N/AN/A$1.39B$20.65M0.004CDRECadre2.2657 of 5 stars$33.60-0.9%$37.50+11.6%+5.6%$1.38B$567.56M35.372,284News CoverageEarnings ReportNVCRNovoCure4.5912 of 5 stars$11.64-3.3%$28.79+147.3%-44.2%$1.34B$605.22M-7.461,488AORTArtivion2.3357 of 5 stars$31.32-0.3%$32.40+3.4%+28.5%$1.34B$388.54M-62.641,600Upcoming EarningsESTAEstablishment Labs1.2817 of 5 stars$42.48+0.2%$54.83+29.1%+28.0%$1.23B$170.24M-13.701,018Upcoming EarningsBLFSBioLife Solutions2.939 of 5 stars$22.23-1.6%$31.00+39.5%-6.2%$1.08B$82.25M-76.65440Positive NewsUpcoming EarningsTNDMTandem Diabetes Care3.7724 of 5 stars$16.84+6.0%$32.71+94.3%-62.9%$1.06B$940.20M-6.062,650News CoveragePositive NewsPLSEPulse Biosciences3.8574 of 5 stars$15.21+1.9%$22.00+44.6%+8.9%$1.00B$700K0.00140Positive NewsMDXGMiMedx Group2.6625 of 5 stars$6.79+0.3%$11.50+69.4%+11.5%$999.94M$348.88M25.15870Positive NewsEarnings ReportINMDInMode3.1401 of 5 stars$14.54-1.2%$18.54+27.5%-14.3%$930.44M$394.82M6.24480Earnings Report Related Companies and Tools Related Companies SS Innovations International Alternatives Cadre Alternatives NovoCure Alternatives Artivion Alternatives Establishment Labs Alternatives BioLife Solutions Alternatives Tandem Diabetes Care Alternatives Pulse Biosciences Alternatives MiMedx Group Alternatives InMode Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
